In mice that were vaccinated with the GRP-fusion HG6 protein before inoculation of breast cancer cells (EMT-6), there was a 3-fold reduction in tumor size compared to that of the control groups (phosphate buffered saline or HSP65-vaccinated mice). This evidence concerns the gene GRP and breast cancer.